S. 4805

S. 4805: A bill to require the United States Executive Directors at the international financial institutions to oppose certain projects involving shrimp production.

Introduced Cindy Hyde-Smith (R) SENATE_BILL — 119th Congress
Plain English Summary

The bill S. 4805 aims to direct U.S. representatives at international financial institutions to oppose funding for certain shrimp production projects. This means that the United States would use its influence to prevent these institutions from financing shrimp farming activities that could harm U.S. shrimp producers.

Positive Media Summary

Supporters of the bill argue that it protects domestic shrimpers from unfair competition by preventing international financial institutions from funding foreign shrimp farms that may not adhere to the same environmental and labor standards as U.S. producers. They believe this measure will help maintain the viability of the U.S. shrimp industry.

Negative Media Summary

Critics contend that the bill could strain diplomatic relations by interfering with the operations of international financial institutions. They also argue that it may limit the availability of shrimp in the U.S. market, potentially leading to higher prices for consumers.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Foreign Trade and International Finance

The analysis of bill S. 4805, which aims to require U.S. Executive Directors at international financial institutions to oppose certain shrimp production projects, reveals no direct industry overlaps between the bill's subject matter and the sponsor, Cindy Hyde-Smith's, top donor industries. The lobbying activity associated with this bill primarily involves organizations that do not appear to have a direct financial interest in shrimp production or related industries. Notably, the largest contributions come from the American College of Clinical Pharmacy ($144,981) and Altria Client Services ($40,000), neither of which are connected to the shrimp industry. This lack of direct financial ties suggests a low risk of conflicts of interest for the sponsor regarding this specific legislation.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
AMERICAN COLLEGE OF CLINICAL PHARMACY AMERICAN COLLEGE OF CLINICAL PHARMACY $144,981
ALTRIA CLIENT SERVICES MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) $40,000
CROHN'S & COLITIS FOUNDATION CROHN'S & COLITIS FOUNDATION $40,000
GOTRIANGLE MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) $30,000
AFRICAN AMERICAN ALLIANCE OF CDFI CEOS MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) $20,000
BRISTOL MYERS SQUIBB ALEXANDER J. BECKLES, L.L.C. $20,000
CITY OF GLADEWATER, TEXAS LONE STAR CONSULTING, LLC $12,000
CITY OF CRANDALL, TEXAS LONE STAR CONSULTING, LLC $10,000
NATIONAL SLEEP FOUNDATION SLEEP, INC. undisclosed
SLEEP, INC. SLEEP, INC. undisclosed
THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES MAGILL ASSOCIATES, LLC undisclosed
OPPORTUNITIES INDUSTRIALIZATION CENTER OF AMERICA, INC. MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) undisclosed
LUMBEE TRIBE HOLDINGS, INC. MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) undisclosed
CITY OF CLEVELAND, TEXAS LONE STAR CONSULTING, LLC undisclosed
CITY OF RIO HONDO, TEXAS LONE STAR CONSULTING, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Cindy Hyde-Smith, ranked by total contributions.

Health Professionals $360,000,000
Individuals: $360,000,000 PACs: $0
Retired $112,500,000
Individuals: $112,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us